Literature DB >> 23507026

Viral infections: contributions to late fetal death, stillbirth, and infant death.

Eleri J Williams1, Nicholas D Embleton, Julia E Clark, Mary Bythell, Martin P Ward Platt, Janet E Berrington.   

Abstract

OBJECTIVE: To determine the role of viral infections in causing fetal and infant death. STUDY
DESIGN: We assessed a well-validated population database of fetal (≥20 weeks gestation) and infant death for infective deaths and deaths from viruses over a 21-year period (1988-2008). We analyzed by specific viral cause, timing (late fetal loss [20-23 weeks], stillbirth [≥24 weeks], neonatal death [0-27 days], and post-neonatal infant death [28-364 days]) and across time.
RESULTS: Of the 989 total infective deaths, 108 were attributable to viral causes (6.5% of late fetal losses, 14.5% of stillbirths, 6.5% of neonatal deaths, and 19.4% of postneonatal infant deaths). Global loss (combined fetal and infant losses per 100,000 registerable births) was 139.6 (95% CI, 130.9-148.3) for any infective cause and 15.2 (95% CI, 12.3-18.1) for viral infections. More than one-third (37%) of viral-attributed deaths were before live birth, from parvovirus (63%) or cytomegalovirus (33%). Parvovirus accounted for 26% (28 of 108) of all viral deaths. Cytomegalovirus was associated with a global loss rate of 3.1 (95% CI, 1.8-4.4) and an infant mortality rate of 1.3 (95% CI, 0.4-2.1) per 100,000 live births; 91% of cases were congenital infections. Herpes simplex virus caused death only after live births (infant mortality rate, 1.4; 95% CI, 0.5-2.3). No changes in rates were seen over time.
CONCLUSION: We have identified a substantial contribution of viral infections to global fetal and infant losses. More than one-third of these losses occurred before live births. Considering our methodology, our estimates represent the minimum contribution of viral illness. Strategies to reduce this burden are needed.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  CMV; Congenital cytomegalovirus; Cytomegalovirus; HSV; Herpes simplex virus; IMR; Infant mortality rate; PMS; Perinatal Mortality Survey; TOP; Termination of pregnancy; cCMV

Mesh:

Year:  2013        PMID: 23507026     DOI: 10.1016/j.jpeds.2013.02.004

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Symptomatic dengue infection during pregnancy and the risk of stillbirth in Brazil, 2006-12: a matched case-control study.

Authors:  Enny S Paixão; Maria da Conceição N Costa; Maria Glória Teixeira; Katie Harron; Marcia Furquim de Almeida; Mauricio L Barreto; Laura C Rodrigues
Journal:  Lancet Infect Dis       Date:  2017-09       Impact factor: 25.071

Review 2.  Dissecting the defects in the neonatal CD8+ T-cell response.

Authors:  Adam J Fike; Ogan K Kumova; Alison J Carey
Journal:  J Leukoc Biol       Date:  2019-07-01       Impact factor: 4.962

3.  Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity.

Authors:  Iara M Backes; Brook K Byrd; Matthew D Slein; Chaya D Patel; Sean A Taylor; Callaghan R Garland; Scott W MacDonald; Alejandro B Balazs; Scott C Davis; Margaret E Ackerman; David A Leib
Journal:  J Exp Med       Date:  2022-09-26       Impact factor: 17.579

Review 4.  Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and prevention.

Authors:  Wendy J van Zuylen; Stuart T Hamilton; Zin Naing; Beverly Hall; Antonia Shand; William D Rawlinson
Journal:  Obstet Med       Date:  2014-09-25

5.  Human Cytomegalovirus Modulates Expression of Noncanonical Wnt Receptor ROR2 To Alter Trophoblast Migration.

Authors:  Wendy J van Zuylen; Caroline E Ford; Diana D Y Wong; William D Rawlinson
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

6.  Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.

Authors:  Fernanda Tavares Da Silva; Bernard Gonik; Mark McMillan; Cheryl Keech; Stephanie Dellicour; Shraddha Bhange; Mihaela Tila; Diana M Harper; Charles Woods; Alison Tse Kawai; Sonali Kochhar; Flor M Munoz
Journal:  Vaccine       Date:  2016-07-16       Impact factor: 3.641

7.  Public Clonotypes and Convergent Recombination Characterize the Naïve CD8+ T-Cell Receptor Repertoire of Extremely Preterm Neonates.

Authors:  Alison J Carey; Jennifer L Hope; Yvonne M Mueller; Adam J Fike; Ogan K Kumova; David B H van Zessen; Eric A P Steegers; Mirjam van der Burg; Peter D Katsikis
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

Review 8.  Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Authors:  Biswajit G Roy
Journal:  Antivir Chem Chemother       Date:  2017-07-23

9.  Adverse effects of maternal enterovirus infection on the pregnancy outcome: a prospective and retrospective pilot study.

Authors:  Z Khediri; C Vauloup-Fellous; A Benachi; J M Ayoubi; L Mandelbrot; O Picone
Journal:  Virol J       Date:  2018-04-16       Impact factor: 4.099

10.  The project to understand and research preterm pregnancy outcomes and stillbirths in South Asia (PURPOSe): a protocol of a prospective, cohort study of causes of mortality among preterm births and stillbirths.

Authors:  Elizabeth M McClure; Sarah Saleem; Shivaprasad S Goudar; Sangappa Dhaded; G Guruprasad; Yogesh Kumar; Shiyam Sunder Tikmani; Masood Kadir; Jamal Raza; Haleema Yasmin; Janet L Moore; Jean Kim; Carla Bann; Lindsay Parlberg; Anna Aceituno; Waldemar A Carlo; Robert M Silver; Laura Lamberti; Janna Patterson; Robert L Goldenberg
Journal:  Reprod Health       Date:  2018-06-22       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.